Health system expenditure 2020-2021 (AIHW)

In 2020-2021, the expenditure for asthma was an estimated $852 million was spent on the treatment and management of asthma, representing 0.6% of total health system expenditure and 19% of expenditure for all respiratory conditions. Specifically:
– Primary care represented 74% of asthma expenditure, about 2.7 times the average portion of primary care for other conditions, and with PBS expenditure in asthma representing more than half (53%) of asthma expenditure (4.7 times the proportion for other conditions)
– hospital services accounted for 21% of asthma expenditure (3 times lower than other conditions), with ED representing 6.23% of asthma expenditure (1.5 times higher proportion than other conditions)
– referred services accounted for 4.8% of asthma expenditure, with Specialist referrals representing 3.4% of asthma expenditure
Asthma accounted for 2.6% of the total (all-cause) PBS expenditure, 1.4% of total GP expenditure, 0.9% of public hospital ED expenditure, 0.5% of specialist services and 0.5% of public hospital outpatient services